Bourgeon Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Bourgeon Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,200	Closed	-$189K	–	466
2022 Q2	$189K	Sell	15,200 -9,818	-39%	-$108K	0.05%	92
2022 Q1	$333K	Buy	25,018 +2,868	+13%	+$38.5K	0.08%	79
2021 Q4	$345K	Buy	22,150 +8,000	+57%	+$153K	0.07%	88
2021 Q3	$318K	Sell	14,150 -250	-2%	-$5.49K	0.07%	91
2021 Q2	$328K	Buy	14,400 +6,400	+80%	+$135K	0.07%	97
2021 Q1	$165K	Buy	8,000 +6,750	+540%	+$154K	0.04%	121
2020 Q4	$35K	Sell	1,250 -7,650	-86%	-$149K	0.01%	161
2020 Q3	$125K	Buy	+8,900	New	+$166K	0.04%	102

Other funds holding MYOV

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bourgeon Capital Management's MYOV Position: Q3 2022 in Review

Bourgeon Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 15,200 shares — an estimated $189K sold.

Bourgeon Capital Management first reported a position in MYOV in Q3 2020 and held it in 8 quarters. The position peaked at $345K in Q4 2021. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

Bourgeon Capital Management reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
Bourgeon Capital Management sold 15,200 Myovant Sciences Ltd. shares in Q3 2022, an estimated $189K.
Bourgeon Capital Management first reported a position in Myovant Sciences Ltd. in Q3 2020 and held it in 8 quarters.
Bourgeon Capital Management's Myovant Sciences Ltd. position peaked at $345K in Q4 2021.
98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Bourgeon Capital Management's 13F filing for Q3 2022, filed 27 Oct 2022.